By Sabrina Valle and Michael Erman Aug 2 (Reuters) – AstraZeneca Plc and Bristol Myers Squibb held preliminary discussions about a possible combination that would create one of the world's biggest
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Democrats planning flood of AI bills when they take control of Congress
By Courtney Rozen WASHINGTON, Nov 6 (Reuters) - Democrats are planning to unleash a flood…
OpenAI secures $11 billion funding at $1.25 trillion valuation, Bloomberg News reports
By Krystal Hu Nov 6 (Reuters) - OpenAI has closed on new funding of $11…
From Chutneys to Chaat: How U.S. Cranberries Are Redefining Diwali Party Starters
New Delhi [India], November 7: As India gears up for Diwali celebrations, festive menus are…
